Insiders · FHTX

Ryan D Maynard

Chief Financial Officer at Foghorn Therapeutics Inc. (FHTX) since February 2026

Ryan D Maynard has filed 16 insider reports with the SEC since July 2021, as director at Iovance Biotherapeutics, Inc. (IOVA), chief Financial Officer at Foghorn Therapeutics Inc. (FHTX) and chief Financial Officer at Cara Therapeutics, Inc. (TVRD). Ryan D Maynard made no open-market purchases or sales in the last 12 months. The latest filing, on June 18, 2026, reports grant or award at Iovance Biotherapeutics, Inc. (IOVA).

Filings
16
Companies
3
Bought on market
$50.6K
Sold on market
$506K

Companies where Ryan D Maynard is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Iovance Biotherapeutics, Inc. logo
IOVA
Iovance Biotherapeutics, Inc.
Director7,500$50.6K$503K$6.75$7.48+11%Jun 18, 2026
Foghorn Therapeutics Inc. logo
FHTX
Foghorn Therapeutics Inc.
Chief Financial Officersince February 2026$1.79Feb 24, 2026
Cara Therapeutics, Inc. logo
TVRD
Cara Therapeutics, Inc.
Chief Financial Officersince September 20228,012$2,909$1.04Feb 12, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Ryan D Maynard with

Other insiders at the same companies

Questions about Ryan D Maynard

What is Ryan D Maynard's role at Foghorn Therapeutics Inc.?
Ryan D Maynard reports to the SEC as chief Financial Officer at Foghorn Therapeutics Inc. (FHTX), according to the latest filing on February 24, 2026. Ryan D Maynard has also filed as director at Iovance Biotherapeutics, Inc. (IOVA) and chief Financial Officer at Cara Therapeutics, Inc. (TVRD).
How many shares does Ryan D Maynard own?
After the latest filing that states it, Ryan D Maynard directly owned 7,500 shares of Iovance Biotherapeutics, Inc. (IOVA) and 8,012 shares of Cara Therapeutics, Inc. (TVRD). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Ryan D Maynard bought or sold stock recently?
The most recent open-market purchase was on May 31, 2022: bought 7,500 shares of Iovance Biotherapeutics, Inc. (IOVA) for $50.6K at an average of $6.75. The most recent open-market sale was on November 12, 2024: sold 50,000 shares of Iovance Biotherapeutics, Inc. (IOVA) for $503K at an average of $10.06.
How do I get alerts when Ryan D Maynard files?
Follow Ryan D Maynard on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Ryan D Maynard (SEC CIK 0001363984). Totals count each trade once, skipping amendments whose original is on file, from Jul 1, 2021 on. View on SEC EDGAR